Neurology Book

http://www.fpnotebook.com/

Mestinon

Advertisement

  1. Indications
    1. Myasthenia Gravis
  2. Components
    1. Neostigmine
    2. Pyridostigmine
  3. Mechanism
    1. Anticholinesterase medications
  4. Dosing
    1. Mestinon 60-120 mg every 3-4 hours
    2. Doses exceeding 120 mg q3 hours are not more effective
  5. Adverse effects (Especially at higher dose)
    1. Gastrointestinal side effects
    2. Muscle Fasciculations
    3. Eye tearing
  6. Efficacy
    1. Not often effective as monotherapy in Myasthenia Gravis

Mestinon (C0700005)

ConceptsOrganic Chemical (T109) , Pharmacologic Substance (T121)
EnglishMestinon
CreditsDerived from the NIH UMLS (Unified Medical Language System)



Navigation Tree